Rongxin Zhang Selected Research

asparaginyl- isoleucyl- prolyl- norvalyl- leucyl- tyrosyl- seryl- phenylalanyl- alanyl- serinamide

1/2017	Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
1/2016	Adiponectin-derived active peptide ADP355 exerts anti-inflammatory and anti-fibrotic activities in thioacetamide-induced liver injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rongxin Zhang Research Topics

Disease

38	Neoplasms (Cancer) 09/2022 - 07/2007
16	Inflammation (Inflammations) 09/2022 - 11/2006
14	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 05/2014
9	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 03/2013
9	Neoplasm Metastasis (Metastasis) 10/2021 - 04/2014
9	Pancreatic Neoplasms (Pancreatic Cancer) 08/2021 - 10/2005
8	Colonic Neoplasms (Colon Cancer) 06/2022 - 09/2009
6	Multiple Sclerosis 01/2019 - 03/2013
5	Carcinogenesis 10/2018 - 05/2014
5	Demyelinating Diseases (Demyelinating Disease) 01/2017 - 03/2013
5	Body Weight (Weight, Body) 01/2016 - 01/2009
4	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 03/2014
4	Melanoma (Melanoma, Malignant) 01/2021 - 01/2018
3	Infections 04/2022 - 09/2009
3	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022 - 02/2016
3	Atherosclerosis 01/2021 - 08/2006
3	Colitis 01/2018 - 05/2014
3	Colitis-Associated Neoplasms 01/2018 - 05/2014
3	Rectal Neoplasms (Rectal Cancer) 01/2018 - 06/2016
3	Liver Cirrhosis (Hepatic Cirrhosis) 12/2016 - 01/2016
2	Carcinoma (Carcinomatosis) 03/2021 - 10/2020
2	Esophageal Neoplasms (Esophageal Cancer) 03/2021 - 10/2020
2	Wounds and Injuries (Trauma) 01/2021 - 10/2020
2	Rupture 11/2020 - 01/2020
2	Neuroinflammatory Diseases 01/2019 - 10/2016
2	Hepatitis 06/2018 - 09/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 10/2015
2	Stomach Neoplasms (Stomach Cancer) 12/2017 - 02/2017
2	Encephalomyelitis (Myeloencephalitis) 01/2017 - 04/2014
2	Reperfusion Injury 01/2017 - 11/2014
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2016 - 11/2014
2	Fibrosis (Cirrhosis) 02/2016 - 04/2010
2	Acquired Immunodeficiency Syndrome (AIDS) 08/2013 - 08/2004
1	Microsatellite Instability 01/2022
1	Adenocarcinoma of Lung 01/2022
1	Vitiligo 09/2021

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 06/2022 - 03/2014
8	Proteins (Proteins, Gene)FDA Link 12/2021 - 11/2006
6	CytokinesIBA 04/2022 - 07/2007
6	Interleukin-6 (Interleukin 6)IBA 12/2021 - 06/2007
6	Therapeutic UsesIBA 01/2021 - 09/2009
6	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2017
6	embelinIBA 01/2018 - 03/2014
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 04/2010
4	arctigeninIBA 01/2021 - 10/2016
4	Biological ProductsIBA 01/2021 - 08/2006
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2019 - 12/2017
4	Capecitabine (Xeloda)FDA Link 10/2019 - 12/2017
4	AdiponectinIBA 01/2017 - 07/2014
3	parthenolideIBA 01/2022 - 09/2016
3	Voltage-Gated Sodium ChannelsIBA 09/2021 - 11/2017
3	Peptides (Polypeptides)IBA 01/2020 - 01/2016
3	LipidsIBA 01/2017 - 01/2009
2	Immune Checkpoint InhibitorsIBA 09/2022 - 01/2020
2	LactonesIBA 01/2022 - 01/2019
2	SesquiterpenesIBA 01/2022 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2020
2	Fluorouracil (Carac)FDA LinkGeneric 09/2021 - 01/2021
2	LigandsIBA 08/2021 - 01/2017
2	Chimeric Antigen ReceptorsIBA 01/2021 - 01/2016
2	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2017
2	ApolipoproteinsIBA 01/2021 - 01/2009
2	Long Noncoding RNAIBA 01/2021 - 12/2017
2	CateninsIBA 01/2021 - 04/2014
2	Messenger RNA (mRNA)IBA 01/2021 - 02/2008
2	SolutionsIBA 10/2020 - 03/2014
2	Histones (Histone)IBA 01/2020 - 10/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 04/2010
2	InflammasomesIBA 12/2019 - 01/2019
2	XELOXIBA 10/2019 - 01/2019
2	PPAR gammaIBA 01/2019 - 07/2010
2	Protein Isoforms (Isoforms)IBA 08/2018 - 11/2017
2	Concanavalin AIBA 06/2018 - 09/2016
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2017 - 11/2014
2	AntigensIBA 01/2017 - 01/2016
2	Sirtuin 1IBA 01/2017 - 07/2014
2	asparaginyl- isoleucyl- prolyl- norvalyl- leucyl- tyrosyl- seryl- phenylalanyl- alanyl- serinamideIBA 01/2017 - 01/2016
2	CollagenIBA 12/2016 - 04/2010
2	plumbaginIBA 12/2016 - 08/2014
2	Conditioned Culture MediaIBA 02/2016 - 06/2007
2	chrysinIBA 11/2015 - 11/2014
2	Insulin (Novolin)FDA Link 01/2012 - 07/2010
2	Triglycerides (Triacylglycerol)IBA 06/2010 - 01/2009
2	C-Reactive ProteinIBA 04/2010 - 11/2006
2	VaccinesIBA 02/2008 - 08/2004
1	p38 Mitogen-Activated Protein KinasesIBA 09/2022
1	Phosphotransferases (Kinase)IBA 09/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 09/2022
1	cordycepinIBA 06/2022
1	Chemokine CCL17IBA 01/2022
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2022
1	calcipotriene (calcipotriol)FDA LinkGeneric 09/2021

Therapy/Procedure

15	Therapeutics 01/2022 - 10/2005
9	Immunotherapy 09/2022 - 01/2016
6	Drug Therapy (Chemotherapy) 01/2020 - 11/2014
4	Adjuvant Chemotherapy 10/2019 - 12/2017
3	Neoadjuvant Therapy 02/2017 - 06/2016
2	Radiotherapy 01/2020 - 01/2020
2	Chemoradiotherapy 01/2018 - 01/2017
1	Phototherapy (Light Therapy) 09/2021